Ritedose to Produce Single-Dose Prefilled Syringes for COVID-19 Vaccines

Statement by Mr. Jody Chastain, Chief Executive Officer
“The Ritedose Corporation is honored and proud to have been selected as a subcontractor to ApiJect for the production of single-dose prefilled syringes intended for administering COVID-19 vaccines. This is a direct result of the commitment demonstrated each day by the talented and dedicated people who work here.

“Founded in 1995 in Columbia, South Carolina, Ritedose is an industry leader in aseptic manufacturing and liquid packaging, and utilizes proven Blow-Fill-Seal (BFS) equipment and processes to ensure efficient, consistent and safe dosage delivery. Our 25-year track record includes the delivery of more than 6 billion doses of drugs since 2012 without a single recall.

“In just a few months, the teams from ApiJect and Ritedose repurposed and upgraded equipment that provides the capacity to fill and finish up to 45 million prefilled syringes per month. Once underway, this work will involve a significant expansion of our Columbia operations and capabilities, which we will support with an increase in our South Carolina workforce.

“We look forward to partnering with ApiJect, the Federal government and relevant oversight and regulatory authorities in this vital effort to overcome COVID-19 and its impact on communities in South Carolina and across the United States.”

Pioneers in aseptic production of sterile, single-dose medication